The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades, liver transplantation (LT) has become the preferable treatment of HCC, when feasible and strict selection criteria are met. With the rise in HCC-related LT, compounded by downstaging techniques and expansion of transplant selection criteria, a parallel increase in number of post-transplantation HCC recurrence is expected. Additionally, in the context of an immunosuppressed transplant host, recurrences may behave aggressively and more challenging to manage, resulting in poor prognosis. Despite this, no consensus or best practice guidelines for post-transplantation cancer surveillance and recurrence management for HCC currently exist. Studies with adequate population sizes and high-level evidence are lacking, and the role of systemic and locoregional therapies for graft and extrahepatic recurrences remains under debate. This review seeks to summarize the existing literature on post-transplant HCC surveillance and recurrence management. It highlights the value of early tumour detection, re-evaluating the immunosuppression regimen, and staging to differentiate disseminated recurrence from intrahepatic or extrahepatic oligo-recurrence. This ultimately guides decision-making and maximizes treatment effect. Treatment recommendations specific to recurrence type are provided based on currently available locoregional and systemic therapies.
Citations
Citations to this article as recorded by
Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomy Jialu Fu, Jiafeng Chen, Lei Jin, Junfeng Huang, Shengwei Mao, Xuhui Zhao, Weifeng Qu, Rui Yang, Yi Wang, Yichao Bu, Zhiqi Guan, Jun Gao, Xiaoling Wu, Qianfu Zhao, Tianhao Chu, Guiqi Zhu, Yuan Fang, Yinghong Shi, Weiren Liu Clinics and Research in Hepatology and Gastroenterology.2026; 50(2): 102750. CrossRef
Lycorine suppresses hepatocellular carcinoma via the reprogramming of myeloid and epithelial cells Xinyu Gu, Fuqiang Ma, Yafeng Liu, Shujun Zhang, Wenjuan Chen, Lifan Zhang, Lele Zhang, Juan Lu, Xinjun Hu Phytomedicine.2026; 150: 157657. CrossRef
CTTN overexpression on circulating tumor cells promotes hepatocellular carcinoma recurrence via enhancing the proliferation and clonality of circulating tumor cells Yongzhi Liu, Zhidong Fu, Lihui Jiang, Yang Chen, Feng Jiang, Chuanling Zhang, Tieming Zhu Cytotechnology.2026;[Epub] CrossRef
Integrating CyTOF with scRNA-seq reveals that Cyclovirobuxine D inhibits HCC progression through hepatic immune microenvironment remodeling Fuqiang Ma, Lele Zhang, Yitao Fan, Ziyi Xu, Yuhua He, Jiachun Sun, Juan Lu, Xinyu Gu Phytomedicine.2026; 150: 157751. CrossRef
A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma J. M. John Britto, T Beula Bell Irish Journal of Medical Science (1971 -).2026;[Epub] CrossRef
Organ Transplantation: Current Status, Challenges, and Future Prospects Xinqiang Li, Ruidong Ding, Jinzhen Cai MedComm.2026;[Epub] CrossRef
Stereotactic radiation therapy for post-transplant systemic recurrence of hepatocellular carcinoma: safety, efficacy and a nomogram predicting overall survival Jingru Chen, Gengmin Niu, Xin Guo, Yuxuan Tao, Xiaobin Liu, Yan Xie, Li Zhang, Wentao Jiang, Peiguo Wang, Zhongqiu Wang, Zhiyong Yuan, Qingxin Wang Frontiers in Oncology.2026;[Epub] CrossRef
Recipient blood group does not affect hepatocellular carcinoma recurrence after living donor liver transplantation in Korea Sung-Min Kim, Shin Hwang, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Young-In Yoon, Woo-Hyoung Kang, Sang-Hoon Kim, Sung-Gyu Lee Surgery Today.2025; 55(1): 99. CrossRef
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Satohiro Masuda, Florian Lemaitre, Markus J. Barten, Stein Bergan, Maria Shipkova, Teun van Gelder, Sander Vinks, Eberhard Wieland, Kirsten Bornemann-Kolatzki, Mercè Brunet, Brenda de Winter, Maja-Theresa Dieterlen, Laure Elens, Taihei Ito, Kamisha Johnso Therapeutic Drug Monitoring.2025; 47(1): 4. CrossRef
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma Ezequiel Mauro, Manuel Rodríguez‐Perálvarez, Antonio D'Alessio, Gonzalo Crespo, Federico Piñero, Eleonora De Martin, Jordi Colmenero, David James Pinato, Alejandro Forner Liver International.2025;[Epub] CrossRef
Analysis of treatment benefits and prognostic factors for posttransplant HCC recurrence in a large Euro-American-Asian cohort Zhihao Li, Itsuko Chih-Yi Chen, Leonardo Centonze, Christian T.J. Magyar, Woo Jin Choi, Sachin Shah, Grainne M. O’Kane, Arndt Vogel, Luciano De Carlis, Jan Lerut, Quirino Lai, Neil Mehta, Chao-Long Chen, Gonzalo Sapisochin Liver Transplantation.2025; 31(4): 450. CrossRef
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapy Shaoru Liu, Zongfeng Wu, Chenwei Wang, Liang Qiao, Zhenkun Huang, Yichuan Yuan, Ruhai Zou, Wei He, Binkui Li, Yunfei Yuan, Jiliang Qiu European Journal of Surgical Oncology.2025; 51(1): 109375. CrossRef
Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation Christian T. J. Magyar, Sheron Perera, Luckshi Rajendran, Zhihao Li, Fahad A. Almugbel, Sophie Feng, Woo Jin Choi, Laia Aceituno, Arndt Vogel, Robert C. Grant, Nazia Selzner, Elmar Jaeckel, Nazanin Falla-Rad, Jennifer J. Knox, Eric X. Chen, Gonzalo Sapiso Transplantation.2025; 109(4): 681. CrossRef
Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study Hwa‐Hee Koh, Minyu Kang, Deok‐Gie Kim, Jae Hyon Park, Eun‐Ki Min, Jae Geun Lee, Myoung Soo Kim, Dong Jin Joo Journal of Gastroenterology and Hepatology.2025; 40(3): 626. CrossRef
Renal metastasis of hepatocellular carcinoma after living donor liver transplantation Yo Nakamura, Jun Kamei, Ryo Tanaka, Yoichi Yasunaga, Nobuhisa Akamatsu, Satoru Taguchi, Shigenori Kakutani, Yuta Yamada, Aya Niimi, Daisuke Yamada, Haruki Kume IJU Case Reports.2025; 8(2): 133. CrossRef
Construction and Validation of a Novel Butyrylation-Related Gene Signature Related to Prognosis, Clinical Implications, and Immune Microenvironment Characterization of Hepatocellular Carcinoma Weiping Su, Yangying Zhou, Xuanxuan Li, Kuo Kang, Hui Nie ACS Omega.2025; 10(4): 3375. CrossRef
ZNF384 and m6A methylation promote the progression of hepatocellular carcinoma by regulating the interaction between LINC00342 and DAPK1 Shujia Kong, Jiaxun Li, Xin Pan, Chen Zhao, Yanwen Li Cellular Signalling.2025; 129: 111666. CrossRef
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction P. Jonathan Li, Parissa Tabrizian, Darine Daher, Felipe Gaviria, Veeral Ajmera, Eleazar E. Montalvan-Sanchez, Julio A. Gutierrez, Kali Zhou, Fanny Delebecque, Nicole Garcia, Bethany Barrick, Christopher Wong, Lauren Nephew, John Holden, Shravan Dave, Gabr Hepatology.2025; 82(6): 1450. CrossRef
Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy Siqi Zhao, Fei Chen, Lingyu Hu, Xiaoping Li, Zhaofeng Gao, Minjie Chen, Xiaoguang Wang, Zhengwei Song Frontiers in Immunology.2025;[Epub] CrossRef
Locoregional and Surgical Treatment of Single-Nodule Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and a Meta-Analysis Marco Maria Pascale, Camilla Marandola, Francesco Frongillo, Erida Nure, Salvatore Agnes Cancers.2025; 17(9): 1501. CrossRef
Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrences of Hepatocellular Carcinoma After Liver Transplantation: A Report of Two Cases Alexander Piening, Alyssa Capizzi, Jeevin Shahi Cureus.2025;[Epub] CrossRef
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma Maen Abdelrahim, Alejandro Mejia, Abdullah Esmail, Juan Carlos Barrera Gutierrez, Mahmoud Ouf, Joseph W. Franses, Irun Bhan, Sudha Kodali, Ashish Saharia, Amit Mahipal, Nikolas Naleid, Catherine Bridges, Antony Tin, Chris M. Brewer, Vasily N. Aushev, Arka JCO Precision Oncology.2025;[Epub] CrossRef
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: The Blind Spot of HCC Management M. Ningarhari, G. Lassailly, S. Dharancy, C. Moreno, E. Trépo United European Gastroenterology Journal.2025; 13(7): 1069. CrossRef
Confirmation of the donor origin of de novo hepatocellular carcinoma after liver transplant using microsatellite analysis Wei Zhang, Jane Houldsworth, Thomas D Schiano, M Isabel Fiel American Journal of Clinical Pathology.2025; 164(3): 492. CrossRef
Exploration Biomarkers for Recurrence of Hepatocellular Carcinoma After Liver Transplantation Based on Bioinformatics Analysis Guangyi Zhu, Shijian Li, Ziyang Luo, Ning Wen, Haibin Li, Yang Fu, Weixuan Li, Jihua Wu, Xuyong Sun Biochemical Genetics.2025;[Epub] CrossRef
Experimental and Clinical Transplantation.2025;[Epub] CrossRef
Integrated microbiome-metabolome profiling unveils a predictive signature for early recurrence in hepatocellular carcinoma Qiqi Chen, Yi Wang, Daoyuan Wu, He Zhang, Qingxin Xia, Dingding Qu Frontiers in Microbiology.2025;[Epub] CrossRef
Comprehensive Bioinformatic Analysis Reveals an Autophagy-related Gene Signature for Predicting Outcome, Immune Status, and Drug Sensitivity in Hepatocellular Carcinoma Peng Liu, Yan Zhou, Shun Zeng, Xiangjuan Chen Recent Patents on Anti-Cancer Drug Discovery.2025; 20(3): 397. CrossRef
Activating transcription factor 4-mediated upregulation of Heat Shock Protein Family A Member 4 promotes hepatocellular carcinoma progression through activation of Wnt/β-catenin/EMT signaling pathway Ruixi Li, Kunnan Wang, Naijing Hou, Yu Tian, Biyan Gong, Min Tang International Journal of Biological Macromolecules.2025; 333: 148850. CrossRef
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, Caterina Vivaldi, Masatoshi Kudo, Shigeo Shimose, Goki Suda, Silvia Camera, Silvia Foti, Mario Domenico Rizzato, Francesca Salani, Naoshi Nishida, Tomotake Shirono, Naoya Sakamoto, Laura Passeri, Mich Hepatology Research.2025;[Epub] CrossRef
SURVEILLANCE AND MANAGEMENT OF POST-TRANSPLANT HEPATOCELLULAR CARCINOMA RECURRENCE Valerio Giannelli, Margherita Spigaroli, Nicola Guglielmo, Gianmauro Berardi, Marco Colasanti, Claudia Telesca, Shirin Demma, Giuseppe Maria Ettorre, Adriano Pellicelli European Journal of Transplantation.2025; 3(2): 77. CrossRef
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations Ashish Kumar, Subrat K. Acharya, Shivaram P. Singh, Ajay Duseja, Kaushal Madan, Akash Shukla, Anil Arora, Anil C. Anand, Ankur Bahl, Arvinder S. Soin, Bhawna Sirohi, Debnarayan Dutta, Dinesh Jothimani, Dipanjan Panda, Gagan Saini, Joy Varghese, Karan Kuma Journal of Clinical and Experimental Hepatology.2024; 14(1): 101269. CrossRef
Three molecular subtypes and a five‐gene signature for hepatocellular carcinoma based on m7G‐related classification Yuan Yue, Jie Tao, Dan An, Lei Shi The Journal of Gene Medicine.2024;[Epub] CrossRef
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea Sojung Han, Do Young Kim, Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park Gut and Liver.2024; 18(1): 116. CrossRef
A Lactic Acid Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironmental Status in Patients with Hepatocellular Carcinoma Zhongcheng Zhou, Bin Wu, Jing Chen, Yiyu Shen, Jing Wang, Xujian Chen, Faming Fei, Mingyuan Zhu Nutrition and Cancer.2024; 76(3): 279. CrossRef
Association between Unplanned Conversion and Patient Survival after Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Propensity Score Matched Analysis Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, MeeYoung Kang, Yeshong Park, Jinju Kim Journal of Clinical Medicine.2024; 13(4): 1116. CrossRef
Indication of Liver Transplant for HCC: Current Status and Future Directions Julian K. Horwitz, Vatche G. Agopian Current Hepatology Reports.2024; 23(1): 185. CrossRef
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology Qiuxiang Zheng, Cuiping Lu, Lian Yu, Ying Zhan, Zhiyong Chen Heliyon.2024; 10(6): e27473. CrossRef
Achieving Textbook Outcomes after Laparoscopic Resection in Posterosuperior Segments of the Liver: The Impact of the Learning Curve Mizelle D’Silva, Jai-Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae-Won Lee, Bo-Ram Lee, Mee-Young Kang, Ye-Shong Park, Jin-Ju Kim Cancers.2024; 16(5): 930. CrossRef
Rapamycin inhibits B16 melanoma cell viability in vitro and in vivo by inducing autophagy and inhibiting the mTOR/p70‑S6k pathway Penghui Wang, Haifang Zhang, Kaikai Guo, Chun Liu, Shimin Chen, Baopeng Pu, Sirun Chen, Tong Feng, Hanyi Jiao, Chang Gao Oncology Letters.2024;[Epub] CrossRef
Commentary: Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases Cuiming Sun, Ying Wen, Jin Zhou Frontiers in Oncology.2024;[Epub] CrossRef
Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma Jing Xu, Yuanyuan Zhao, Zhishui Chen, Lai Wei Journal of Personalized Medicine.2024; 14(4): 420. CrossRef
Atypical case of hepatoma recurrence two years post-transplant Syed Muhammad Sinaan Ali, Abdul Haseeb, Muhammad Ashir Shafique, Muhammad Saqlain Mustafa, Naeemullah Arbani, Syeda Zainab Fatima Journal of Medicine, Surgery, and Public Health.2024; 3: 100101. CrossRef
FOXM1 Upregulates O-GlcNAcylation Level Via The Hexosamine Biosynthesis Pathway to Promote Angiogenesis in Hepatocellular Carcinoma Xiaorong Zhang, Yifan Zhong, Qing Yang Cell Biochemistry and Biophysics.2024; 82(3): 2767. CrossRef
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study William Chung, Kevin Wong, Noel Ravindranayagam, Lauren Tang, Josephine Grace, Darren Wong, Danny Con, Marie Sinclair, Avik Majumdar, Numan Kutaiba, Samuel Hui, Paul Gow, Vijayaragavan Muralidharan, Alexander Dobrovic, Adam Testro World Journal of Transplantation.2024;[Epub] CrossRef
Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies Ezequiel Mauro, Marco Sanduzzi-Zamparelli, Gabrielle Jutras, Raquel Garcia, Alexandre Soler Perromat, Neus Llarch, Victor Holguin Arce, Pablo Ruiz, Jordi Rimola, Eva Lopez, Joana Ferrer-Fàbrega, Ángeles García-Criado, Jordi Colmenero, Jennifer C. Lai, Ale Cancers.2024; 16(17): 3059. CrossRef
Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: a retrospective multicentric cohort study Deok-Gie Kim, Shin Hwang, Kwang-Woong Lee, Jong Man Kim, Young Kyoung You, Donglak Choi, Je Ho Ryu, Bong-Wan Kim, Dong-Sik Kim, Jai Young Cho, Yang Won Nah, Man ki Ju, Tae-Seok Kim, Jae Geun Lee, Myoung Soo Kim, Alessandro Parente, Ki-Hun Kim, Andrea Schl International Journal of Surgery.2024; 110(8): 4859. CrossRef
Postoperative adjuvant immunotherapy and molecular targeted therapy for patients of hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy: a propensity score matching study Jiangmin Zhou, Huifang Xiong, Zhiwei Zhang, Dong Chen, Wei Wang, Cheng Zhou, Biao Wu Frontiers in Surgery.2024;[Epub] CrossRef
The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions Jianbo Ning, Yutao Wang, Zijia Tao Frontiers in Immunology.2024;[Epub] CrossRef
Are Ki-67 and Procalcitonin Expression Levels Useful in Predicting the Biological Behavior of Hepatocellular Carcinoma After Liver Transplantation? Ertugrul Karabulut, Sami Akbulut, Emine Turkmen Samdanci, Ayse Nur Akatli, Ahmed Elsarawy, Zeynep Kucukakcali, Zeki Ogut, Adem Tuncer, Volkan Ince, Sezai Yilmaz Journal of Clinical Medicine.2024; 14(1): 144. CrossRef
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Myung Ji Goh, Wonseok Kang, Seung Up Kim European Journal of Gastroenterology & Hepatology.2023; 35(2): 191. CrossRef
Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty International Journal of Molecular Sciences.2023; 24(3): 2358. CrossRef
Main factors influencing long-term outcomes of liver transplantation in 2022 Elisa Fuochi, Lorenzo Anastasio, Erica Nicola Lynch, Claudia Campani, Gabriele Dragoni, Stefano Milani, Andrea Galli, Tommaso Innocenti World Journal of Hepatology.2023; 15(3): 321. CrossRef
Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells Huan Liu, Wenchao Zhang, Lijie Jin, Shasha Liu, Liying Liang, Yanfei Wei International Journal of Molecular Sciences.2023; 24(7): 6279. CrossRef
Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection Hamzah Adwan, Lars Hammann, Thomas J. Vogl Journal of Clinical Medicine.2023; 12(7): 2560. CrossRef
An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC) Wei Huang, Jia Mei, Yuan-Jie Liu, Jie-Pin Li, Xi Zou, Xiao-Ping Qian, Yu Zhang Journal of Hepatocellular Carcinoma.2023; Volume 10: 497. CrossRef
LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection Chunhui Zhang, Rui Yang, Xinxin Wang, Yuqing Tao, Shuli Tang, Zhennan Tian, Yang Zhou Annals of Surgical Oncology.2023; 30(8): 4876. CrossRef
The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo Current Oncology.2023; 30(6): 5574. CrossRef
High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro Weiming Zhao, Lingling Xi, Guoying Yu, Gaiping Wang, Cuifang Chang Journal of Cell Communication and Signaling.2023; 17(4): 1435. CrossRef
SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang Journal of Cancer Research and Clinical Oncology.2023; 149(13): 12033. CrossRef
Sequencing Systemic Therapy in Hepatocellular Carcinoma Ben Ponvilawan, Marc T. Roth Current Treatment Options in Oncology.2023; 24(11): 1580. CrossRef
The current role of radiofrequency ablation in the treatment of intrahepatic recurrent hepatocellular carcinoma Rong Fu, Wenwu Ling Journal of Surgical Oncology.2023; 128(8): 1340. CrossRef
Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh Annals of Liver Transplantation.2023; 3(2): 104. CrossRef
Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He, Wei-Qiang Chen Frontiers in Oncology.2023;[Epub] CrossRef
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review Sang Jin Kim, Jong Man Kim Clinical and Molecular Hepatology.2022; 28(4): 739. CrossRef
Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series Ta-Hsiang Wong, Cheng-Maw Ho, Hsao-Hsun Hsu, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee, Rey-Heng Hu Journal of Hepatocellular Carcinoma.2022; Volume 9: 1081. CrossRef
First
Prev
